nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—MAOB—Alzheimer's disease	0.338	0.759	CbGaD
Tranylcypromine—CYP2D6—Alzheimer's disease	0.108	0.241	CbGaD
Tranylcypromine—CYP2A6—Memantine—Alzheimer's disease	0.107	0.284	CbGbCtD
Tranylcypromine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0486	0.129	CbGbCtD
Tranylcypromine—CYP2C19—Memantine—Alzheimer's disease	0.0443	0.117	CbGbCtD
Tranylcypromine—CYP2C9—Donepezil—Alzheimer's disease	0.0425	0.112	CbGbCtD
Tranylcypromine—CYP2D6—Donepezil—Alzheimer's disease	0.0389	0.103	CbGbCtD
Tranylcypromine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0309	0.0818	CbGbCtD
Tranylcypromine—CYP2D6—Galantamine—Alzheimer's disease	0.025	0.0663	CbGbCtD
Tranylcypromine—CYP3A4—Donepezil—Alzheimer's disease	0.0247	0.0654	CbGbCtD
Tranylcypromine—CYP3A4—Galantamine—Alzheimer's disease	0.0159	0.0421	CbGbCtD
Tranylcypromine—MAOA—locus ceruleus—Alzheimer's disease	0.00357	0.315	CbGeAlD
Tranylcypromine—Haemorrhage intracranial—Donepezil—Alzheimer's disease	0.00247	0.0239	CcSEcCtD
Tranylcypromine—Stiffness—Rivastigmine—Alzheimer's disease	0.00237	0.0229	CcSEcCtD
Tranylcypromine—Haemorrhage intracranial—Memantine—Alzheimer's disease	0.00225	0.0217	CcSEcCtD
Tranylcypromine—Haemorrhage intracranial—Rivastigmine—Alzheimer's disease	0.0022	0.0212	CcSEcCtD
Tranylcypromine—Inappropriate antidiuretic hormone secretion—Memantine—Alzheimer's disease	0.00159	0.0153	CcSEcCtD
Tranylcypromine—Myoclonus—Memantine—Alzheimer's disease	0.00153	0.0148	CcSEcCtD
Tranylcypromine—Myoclonus—Rivastigmine—Alzheimer's disease	0.0015	0.0145	CcSEcCtD
Tranylcypromine—Urinary incontinence—Galantamine—Alzheimer's disease	0.00126	0.0122	CcSEcCtD
Tranylcypromine—Numbness—Donepezil—Alzheimer's disease	0.00122	0.0118	CcSEcCtD
Tranylcypromine—Sensory loss—Donepezil—Alzheimer's disease	0.00117	0.0113	CcSEcCtD
Tranylcypromine—Numbness—Memantine—Alzheimer's disease	0.00111	0.0107	CcSEcCtD
Tranylcypromine—Pallor—Memantine—Alzheimer's disease	0.00111	0.0107	CcSEcCtD
Tranylcypromine—Pallor—Rivastigmine—Alzheimer's disease	0.00109	0.0105	CcSEcCtD
Tranylcypromine—Sensory loss—Memantine—Alzheimer's disease	0.00106	0.0103	CcSEcCtD
Tranylcypromine—Musculoskeletal stiffness—Rivastigmine—Alzheimer's disease	0.001	0.0097	CcSEcCtD
Tranylcypromine—Urinary incontinence—Donepezil—Alzheimer's disease	0.00098	0.00946	CcSEcCtD
Tranylcypromine—Urinary retention—Galantamine—Alzheimer's disease	0.000904	0.00872	CcSEcCtD
Tranylcypromine—Ataxia—Galantamine—Alzheimer's disease	0.000894	0.00863	CcSEcCtD
Tranylcypromine—Urinary incontinence—Memantine—Alzheimer's disease	0.00089	0.00859	CcSEcCtD
Tranylcypromine—Urinary incontinence—Rivastigmine—Alzheimer's disease	0.00087	0.0084	CcSEcCtD
Tranylcypromine—Pollakiuria—Galantamine—Alzheimer's disease	0.000759	0.00733	CcSEcCtD
Tranylcypromine—Disorientation—Memantine—Alzheimer's disease	0.000748	0.00722	CcSEcCtD
Tranylcypromine—Amnesia—Memantine—Alzheimer's disease	0.000712	0.00687	CcSEcCtD
Tranylcypromine—Urinary retention—Donepezil—Alzheimer's disease	0.0007	0.00676	CcSEcCtD
Tranylcypromine—Amnesia—Rivastigmine—Alzheimer's disease	0.000696	0.00672	CcSEcCtD
Tranylcypromine—Ataxia—Donepezil—Alzheimer's disease	0.000693	0.00669	CcSEcCtD
Tranylcypromine—Bradycardia—Galantamine—Alzheimer's disease	0.000669	0.00646	CcSEcCtD
Tranylcypromine—Haemoglobin—Galantamine—Alzheimer's disease	0.000661	0.00638	CcSEcCtD
Tranylcypromine—Haemorrhage—Galantamine—Alzheimer's disease	0.000657	0.00635	CcSEcCtD
Tranylcypromine—Hepatitis—Galantamine—Alzheimer's disease	0.000657	0.00635	CcSEcCtD
Tranylcypromine—Urinary retention—Memantine—Alzheimer's disease	0.000636	0.00614	CcSEcCtD
Tranylcypromine—Ataxia—Memantine—Alzheimer's disease	0.000629	0.00607	CcSEcCtD
Tranylcypromine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000622	0.00601	CcSEcCtD
Tranylcypromine—Ataxia—Rivastigmine—Alzheimer's disease	0.000615	0.00594	CcSEcCtD
Tranylcypromine—Tinnitus—Galantamine—Alzheimer's disease	0.000613	0.00592	CcSEcCtD
Tranylcypromine—Flushing—Galantamine—Alzheimer's disease	0.00061	0.00589	CcSEcCtD
Tranylcypromine—Pollakiuria—Donepezil—Alzheimer's disease	0.000588	0.00568	CcSEcCtD
Tranylcypromine—MAOB—embryo—Alzheimer's disease	0.000586	0.0517	CbGeAlD
Tranylcypromine—Muscle spasms—Galantamine—Alzheimer's disease	0.00055	0.00531	CcSEcCtD
Tranylcypromine—Sweating—Donepezil—Alzheimer's disease	0.000544	0.00525	CcSEcCtD
Tranylcypromine—Vision blurred—Galantamine—Alzheimer's disease	0.000539	0.00521	CcSEcCtD
Tranylcypromine—Tremor—Galantamine—Alzheimer's disease	0.000536	0.00518	CcSEcCtD
Tranylcypromine—Pollakiuria—Memantine—Alzheimer's disease	0.000534	0.00515	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000532	0.00514	CcSEcCtD
Tranylcypromine—Anaemia—Galantamine—Alzheimer's disease	0.000529	0.00511	CcSEcCtD
Tranylcypromine—Agitation—Galantamine—Alzheimer's disease	0.000526	0.00508	CcSEcCtD
Tranylcypromine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000522	0.00504	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000521	0.00503	CcSEcCtD
Tranylcypromine—Bradycardia—Donepezil—Alzheimer's disease	0.000519	0.00501	CcSEcCtD
Tranylcypromine—MAOB—forebrain—Alzheimer's disease	0.000518	0.0457	CbGeAlD
Tranylcypromine—Syncope—Galantamine—Alzheimer's disease	0.000513	0.00495	CcSEcCtD
Tranylcypromine—Haemoglobin—Donepezil—Alzheimer's disease	0.000512	0.00494	CcSEcCtD
Tranylcypromine—Haemorrhage—Donepezil—Alzheimer's disease	0.00051	0.00492	CcSEcCtD
Tranylcypromine—Hepatitis—Donepezil—Alzheimer's disease	0.00051	0.00492	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000507	0.00489	CcSEcCtD
Tranylcypromine—Palpitations—Galantamine—Alzheimer's disease	0.000506	0.00488	CcSEcCtD
Tranylcypromine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000504	0.00487	CcSEcCtD
Tranylcypromine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000503	0.00486	CcSEcCtD
Tranylcypromine—MAOA—embryo—Alzheimer's disease	0.0005	0.0441	CbGeAlD
Tranylcypromine—Phentermine—MAOB—Alzheimer's disease	0.000496	0.22	CrCbGaD
Tranylcypromine—Hypertension—Galantamine—Alzheimer's disease	0.000494	0.00477	CcSEcCtD
Tranylcypromine—Anxiety—Galantamine—Alzheimer's disease	0.000486	0.00469	CcSEcCtD
Tranylcypromine—Sweating—Rivastigmine—Alzheimer's disease	0.000483	0.00467	CcSEcCtD
Tranylcypromine—Agranulocytosis—Memantine—Alzheimer's disease	0.000481	0.00464	CcSEcCtD
Tranylcypromine—Dry mouth—Galantamine—Alzheimer's disease	0.000477	0.0046	CcSEcCtD
Tranylcypromine—MAOB—telencephalon—Alzheimer's disease	0.000476	0.042	CbGeAlD
Tranylcypromine—Tinnitus—Donepezil—Alzheimer's disease	0.000475	0.00459	CcSEcCtD
Tranylcypromine—Confusional state—Galantamine—Alzheimer's disease	0.000471	0.00455	CcSEcCtD
Tranylcypromine—Bradycardia—Memantine—Alzheimer's disease	0.000471	0.00455	CcSEcCtD
Tranylcypromine—Haemoglobin—Memantine—Alzheimer's disease	0.000465	0.00449	CcSEcCtD
Tranylcypromine—Haemorrhage—Memantine—Alzheimer's disease	0.000463	0.00447	CcSEcCtD
Tranylcypromine—Hepatitis—Memantine—Alzheimer's disease	0.000463	0.00447	CcSEcCtD
Tranylcypromine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000461	0.00445	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Memantine—Alzheimer's disease	0.00046	0.00444	CcSEcCtD
Tranylcypromine—Shock—Galantamine—Alzheimer's disease	0.00046	0.00444	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000457	0.00442	CcSEcCtD
Tranylcypromine—Chills—Donepezil—Alzheimer's disease	0.000457	0.00441	CcSEcCtD
Tranylcypromine—Tachycardia—Galantamine—Alzheimer's disease	0.000456	0.0044	CcSEcCtD
Tranylcypromine—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000455	0.00439	CcSEcCtD
Tranylcypromine—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000453	0.00437	CcSEcCtD
Tranylcypromine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000453	0.00437	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000452	0.00436	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00045	0.00435	CcSEcCtD
Tranylcypromine—Alopecia—Donepezil—Alzheimer's disease	0.00045	0.00435	CcSEcCtD
Tranylcypromine—Anorexia—Galantamine—Alzheimer's disease	0.000445	0.0043	CcSEcCtD
Tranylcypromine—MAOA—forebrain—Alzheimer's disease	0.000442	0.039	CbGeAlD
Tranylcypromine—Hypotension—Galantamine—Alzheimer's disease	0.000436	0.00421	CcSEcCtD
Tranylcypromine—Tinnitus—Memantine—Alzheimer's disease	0.000431	0.00416	CcSEcCtD
Tranylcypromine—Flushing—Memantine—Alzheimer's disease	0.000429	0.00414	CcSEcCtD
Tranylcypromine—Muscle spasms—Donepezil—Alzheimer's disease	0.000426	0.00412	CcSEcCtD
Tranylcypromine—Insomnia—Galantamine—Alzheimer's disease	0.000422	0.00408	CcSEcCtD
Tranylcypromine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000422	0.00407	CcSEcCtD
Tranylcypromine—Flushing—Rivastigmine—Alzheimer's disease	0.00042	0.00405	CcSEcCtD
Tranylcypromine—Paraesthesia—Galantamine—Alzheimer's disease	0.000419	0.00405	CcSEcCtD
Tranylcypromine—Vision blurred—Donepezil—Alzheimer's disease	0.000418	0.00404	CcSEcCtD
Tranylcypromine—Tremor—Donepezil—Alzheimer's disease	0.000416	0.00401	CcSEcCtD
Tranylcypromine—Somnolence—Galantamine—Alzheimer's disease	0.000415	0.00401	CcSEcCtD
Tranylcypromine—Chills—Memantine—Alzheimer's disease	0.000415	0.00401	CcSEcCtD
Tranylcypromine—Anaemia—Donepezil—Alzheimer's disease	0.00041	0.00396	CcSEcCtD
Tranylcypromine—Alopecia—Memantine—Alzheimer's disease	0.000409	0.00395	CcSEcCtD
Tranylcypromine—Agitation—Donepezil—Alzheimer's disease	0.000408	0.00393	CcSEcCtD
Tranylcypromine—MAOA—telencephalon—Alzheimer's disease	0.000406	0.0358	CbGeAlD
Tranylcypromine—Chills—Rivastigmine—Alzheimer's disease	0.000406	0.00392	CcSEcCtD
Tranylcypromine—Decreased appetite—Galantamine—Alzheimer's disease	0.000406	0.00392	CcSEcCtD
Tranylcypromine—Phenelzine—MAOB—Alzheimer's disease	0.000405	0.179	CrCbGaD
Tranylcypromine—Alopecia—Rivastigmine—Alzheimer's disease	0.0004	0.00386	CcSEcCtD
Tranylcypromine—Constipation—Galantamine—Alzheimer's disease	0.000399	0.00386	CcSEcCtD
Tranylcypromine—Syncope—Donepezil—Alzheimer's disease	0.000398	0.00384	CcSEcCtD
Tranylcypromine—Loss of consciousness—Donepezil—Alzheimer's disease	0.00039	0.00376	CcSEcCtD
Tranylcypromine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000385	0.00372	CcSEcCtD
Tranylcypromine—Hypertension—Donepezil—Alzheimer's disease	0.000383	0.0037	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000382	0.00369	CcSEcCtD
Tranylcypromine—Amphetamine—MAOB—Alzheimer's disease	0.000382	0.169	CrCbGaD
Tranylcypromine—Vision blurred—Memantine—Alzheimer's disease	0.00038	0.00366	CcSEcCtD
Tranylcypromine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000379	0.00366	CcSEcCtD
Tranylcypromine—Tremor—Memantine—Alzheimer's disease	0.000377	0.00364	CcSEcCtD
Tranylcypromine—Anxiety—Donepezil—Alzheimer's disease	0.000376	0.00363	CcSEcCtD
Tranylcypromine—Anaemia—Memantine—Alzheimer's disease	0.000372	0.00359	CcSEcCtD
Tranylcypromine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000371	0.00358	CcSEcCtD
Tranylcypromine—Agitation—Memantine—Alzheimer's disease	0.00037	0.00357	CcSEcCtD
Tranylcypromine—Dry mouth—Donepezil—Alzheimer's disease	0.000369	0.00357	CcSEcCtD
Tranylcypromine—Body temperature increased—Galantamine—Alzheimer's disease	0.000369	0.00356	CcSEcCtD
Tranylcypromine—Abdominal pain—Galantamine—Alzheimer's disease	0.000369	0.00356	CcSEcCtD
Tranylcypromine—Tremor—Rivastigmine—Alzheimer's disease	0.000369	0.00356	CcSEcCtD
Tranylcypromine—Confusional state—Donepezil—Alzheimer's disease	0.000365	0.00352	CcSEcCtD
Tranylcypromine—Anaemia—Rivastigmine—Alzheimer's disease	0.000364	0.00352	CcSEcCtD
Tranylcypromine—Agitation—Rivastigmine—Alzheimer's disease	0.000362	0.0035	CcSEcCtD
Tranylcypromine—Oedema—Donepezil—Alzheimer's disease	0.000362	0.00349	CcSEcCtD
Tranylcypromine—Syncope—Memantine—Alzheimer's disease	0.000361	0.00349	CcSEcCtD
Tranylcypromine—Leukopenia—Memantine—Alzheimer's disease	0.00036	0.00348	CcSEcCtD
Tranylcypromine—CYP2A6—cerebellum—Alzheimer's disease	0.000359	0.0316	CbGeAlD
Tranylcypromine—Shock—Donepezil—Alzheimer's disease	0.000356	0.00344	CcSEcCtD
Tranylcypromine—Palpitations—Memantine—Alzheimer's disease	0.000356	0.00344	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000354	0.00342	CcSEcCtD
Tranylcypromine—Loss of consciousness—Memantine—Alzheimer's disease	0.000354	0.00342	CcSEcCtD
Tranylcypromine—Syncope—Rivastigmine—Alzheimer's disease	0.000353	0.00341	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00035	0.00338	CcSEcCtD
Tranylcypromine—Palpitations—Rivastigmine—Alzheimer's disease	0.000348	0.00336	CcSEcCtD
Tranylcypromine—Hypertension—Memantine—Alzheimer's disease	0.000348	0.00336	CcSEcCtD
Tranylcypromine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000346	0.00334	CcSEcCtD
Tranylcypromine—Anorexia—Donepezil—Alzheimer's disease	0.000345	0.00333	CcSEcCtD
Tranylcypromine—Anxiety—Memantine—Alzheimer's disease	0.000342	0.0033	CcSEcCtD
Tranylcypromine—Hypertension—Rivastigmine—Alzheimer's disease	0.00034	0.00328	CcSEcCtD
Tranylcypromine—Hypotension—Donepezil—Alzheimer's disease	0.000338	0.00327	CcSEcCtD
Tranylcypromine—Dry mouth—Memantine—Alzheimer's disease	0.000335	0.00324	CcSEcCtD
Tranylcypromine—Asthenia—Galantamine—Alzheimer's disease	0.000335	0.00324	CcSEcCtD
Tranylcypromine—Anxiety—Rivastigmine—Alzheimer's disease	0.000334	0.00323	CcSEcCtD
Tranylcypromine—Confusional state—Memantine—Alzheimer's disease	0.000331	0.0032	CcSEcCtD
Tranylcypromine—Oedema—Memantine—Alzheimer's disease	0.000329	0.00317	CcSEcCtD
Tranylcypromine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000328	0.00317	CcSEcCtD
Tranylcypromine—Insomnia—Donepezil—Alzheimer's disease	0.000327	0.00316	CcSEcCtD
Tranylcypromine—Paraesthesia—Donepezil—Alzheimer's disease	0.000325	0.00314	CcSEcCtD
Tranylcypromine—Confusional state—Rivastigmine—Alzheimer's disease	0.000324	0.00313	CcSEcCtD
Tranylcypromine—Shock—Memantine—Alzheimer's disease	0.000323	0.00312	CcSEcCtD
Tranylcypromine—Somnolence—Donepezil—Alzheimer's disease	0.000322	0.00311	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000322	0.00311	CcSEcCtD
Tranylcypromine—Oedema—Rivastigmine—Alzheimer's disease	0.000322	0.0031	CcSEcCtD
Tranylcypromine—Tachycardia—Memantine—Alzheimer's disease	0.000321	0.0031	CcSEcCtD
Tranylcypromine—Diarrhoea—Galantamine—Alzheimer's disease	0.00032	0.00309	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000318	0.00307	CcSEcCtD
Tranylcypromine—Shock—Rivastigmine—Alzheimer's disease	0.000316	0.00305	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000315	0.00304	CcSEcCtD
Tranylcypromine—Decreased appetite—Donepezil—Alzheimer's disease	0.000315	0.00304	CcSEcCtD
Tranylcypromine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000314	0.00303	CcSEcCtD
Tranylcypromine—Anorexia—Memantine—Alzheimer's disease	0.000313	0.00302	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000311	0.003	CcSEcCtD
Tranylcypromine—Pain—Donepezil—Alzheimer's disease	0.00031	0.00299	CcSEcCtD
Tranylcypromine—Constipation—Donepezil—Alzheimer's disease	0.00031	0.00299	CcSEcCtD
Tranylcypromine—Dizziness—Galantamine—Alzheimer's disease	0.000309	0.00298	CcSEcCtD
Tranylcypromine—Hypotension—Memantine—Alzheimer's disease	0.000307	0.00296	CcSEcCtD
Tranylcypromine—Anorexia—Rivastigmine—Alzheimer's disease	0.000306	0.00296	CcSEcCtD
Tranylcypromine—CYP2E1—telencephalon—Alzheimer's disease	0.000305	0.0269	CbGeAlD
Tranylcypromine—Hypotension—Rivastigmine—Alzheimer's disease	0.0003	0.0029	CcSEcCtD
Tranylcypromine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000298	0.00288	CcSEcCtD
Tranylcypromine—Insomnia—Memantine—Alzheimer's disease	0.000297	0.00287	CcSEcCtD
Tranylcypromine—Vomiting—Galantamine—Alzheimer's disease	0.000297	0.00287	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000296	0.00286	CcSEcCtD
Tranylcypromine—Paraesthesia—Memantine—Alzheimer's disease	0.000295	0.00285	CcSEcCtD
Tranylcypromine—Rash—Galantamine—Alzheimer's disease	0.000295	0.00284	CcSEcCtD
Tranylcypromine—Dermatitis—Galantamine—Alzheimer's disease	0.000294	0.00284	CcSEcCtD
Tranylcypromine—Headache—Galantamine—Alzheimer's disease	0.000293	0.00282	CcSEcCtD
Tranylcypromine—Somnolence—Memantine—Alzheimer's disease	0.000292	0.00282	CcSEcCtD
Tranylcypromine—CYP2A6—brain—Alzheimer's disease	0.000291	0.0257	CbGeAlD
Tranylcypromine—Insomnia—Rivastigmine—Alzheimer's disease	0.000291	0.00281	CcSEcCtD
Tranylcypromine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000289	0.00279	CcSEcCtD
Tranylcypromine—Urticaria—Donepezil—Alzheimer's disease	0.000288	0.00278	CcSEcCtD
Tranylcypromine—Abdominal pain—Donepezil—Alzheimer's disease	0.000286	0.00276	CcSEcCtD
Tranylcypromine—Body temperature increased—Donepezil—Alzheimer's disease	0.000286	0.00276	CcSEcCtD
Tranylcypromine—Somnolence—Rivastigmine—Alzheimer's disease	0.000286	0.00276	CcSEcCtD
Tranylcypromine—Decreased appetite—Memantine—Alzheimer's disease	0.000286	0.00276	CcSEcCtD
Tranylcypromine—MAOB—nervous system—Alzheimer's disease	0.000281	0.0248	CbGeAlD
Tranylcypromine—Pain—Memantine—Alzheimer's disease	0.000281	0.00271	CcSEcCtD
Tranylcypromine—Constipation—Memantine—Alzheimer's disease	0.000281	0.00271	CcSEcCtD
Tranylcypromine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00028	0.0027	CcSEcCtD
Tranylcypromine—Nausea—Galantamine—Alzheimer's disease	0.000277	0.00268	CcSEcCtD
Tranylcypromine—Constipation—Rivastigmine—Alzheimer's disease	0.000275	0.00265	CcSEcCtD
Tranylcypromine—Pain—Rivastigmine—Alzheimer's disease	0.000275	0.00265	CcSEcCtD
Tranylcypromine—Feeling abnormal—Memantine—Alzheimer's disease	0.000271	0.00261	CcSEcCtD
Tranylcypromine—MAOB—central nervous system—Alzheimer's disease	0.000271	0.0239	CbGeAlD
Tranylcypromine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000269	0.00259	CcSEcCtD
Tranylcypromine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000265	0.00256	CcSEcCtD
Tranylcypromine—MAOB—cerebellum—Alzheimer's disease	0.000265	0.0233	CbGeAlD
Tranylcypromine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000263	0.00254	CcSEcCtD
Tranylcypromine—CYP2D6—forebrain—Alzheimer's disease	0.000263	0.0232	CbGeAlD
Tranylcypromine—Urticaria—Memantine—Alzheimer's disease	0.000261	0.00252	CcSEcCtD
Tranylcypromine—Abdominal pain—Memantine—Alzheimer's disease	0.00026	0.00251	CcSEcCtD
Tranylcypromine—Body temperature increased—Memantine—Alzheimer's disease	0.00026	0.00251	CcSEcCtD
Tranylcypromine—Asthenia—Donepezil—Alzheimer's disease	0.00026	0.00251	CcSEcCtD
Tranylcypromine—Urticaria—Rivastigmine—Alzheimer's disease	0.000255	0.00247	CcSEcCtD
Tranylcypromine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000254	0.00245	CcSEcCtD
Tranylcypromine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000254	0.00245	CcSEcCtD
Tranylcypromine—Diarrhoea—Donepezil—Alzheimer's disease	0.000248	0.00239	CcSEcCtD
Tranylcypromine—CYP2D6—telencephalon—Alzheimer's disease	0.000242	0.0213	CbGeAlD
Tranylcypromine—MAOA—nervous system—Alzheimer's disease	0.00024	0.0212	CbGeAlD
Tranylcypromine—Dizziness—Donepezil—Alzheimer's disease	0.000239	0.00231	CcSEcCtD
Tranylcypromine—Asthenia—Memantine—Alzheimer's disease	0.000236	0.00228	CcSEcCtD
Tranylcypromine—MAOA—central nervous system—Alzheimer's disease	0.000231	0.0204	CbGeAlD
Tranylcypromine—Asthenia—Rivastigmine—Alzheimer's disease	0.000231	0.00223	CcSEcCtD
Tranylcypromine—Vomiting—Donepezil—Alzheimer's disease	0.00023	0.00222	CcSEcCtD
Tranylcypromine—Rash—Donepezil—Alzheimer's disease	0.000228	0.0022	CcSEcCtD
Tranylcypromine—Dermatitis—Donepezil—Alzheimer's disease	0.000228	0.0022	CcSEcCtD
Tranylcypromine—Headache—Donepezil—Alzheimer's disease	0.000227	0.00219	CcSEcCtD
Tranylcypromine—MAOA—cerebellum—Alzheimer's disease	0.000226	0.0199	CbGeAlD
Tranylcypromine—Diarrhoea—Memantine—Alzheimer's disease	0.000225	0.00217	CcSEcCtD
Tranylcypromine—Phentermine—SLC6A4—Alzheimer's disease	0.000224	0.0992	CrCbGaD
Tranylcypromine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00022	0.00212	CcSEcCtD
Tranylcypromine—Dizziness—Memantine—Alzheimer's disease	0.000217	0.0021	CcSEcCtD
Tranylcypromine—Nausea—Donepezil—Alzheimer's disease	0.000215	0.00208	CcSEcCtD
Tranylcypromine—MAOB—brain—Alzheimer's disease	0.000215	0.019	CbGeAlD
Tranylcypromine—Dizziness—Rivastigmine—Alzheimer's disease	0.000213	0.00205	CcSEcCtD
Tranylcypromine—Vomiting—Memantine—Alzheimer's disease	0.000209	0.00202	CcSEcCtD
Tranylcypromine—Rash—Memantine—Alzheimer's disease	0.000207	0.002	CcSEcCtD
Tranylcypromine—Dermatitis—Memantine—Alzheimer's disease	0.000207	0.002	CcSEcCtD
Tranylcypromine—Headache—Memantine—Alzheimer's disease	0.000206	0.00199	CcSEcCtD
Tranylcypromine—Vomiting—Rivastigmine—Alzheimer's disease	0.000204	0.00197	CcSEcCtD
Tranylcypromine—Rash—Rivastigmine—Alzheimer's disease	0.000203	0.00196	CcSEcCtD
Tranylcypromine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000203	0.00196	CcSEcCtD
Tranylcypromine—Headache—Rivastigmine—Alzheimer's disease	0.000201	0.00194	CcSEcCtD
Tranylcypromine—Nausea—Memantine—Alzheimer's disease	0.000195	0.00188	CcSEcCtD
Tranylcypromine—Nausea—Rivastigmine—Alzheimer's disease	0.000191	0.00184	CcSEcCtD
Tranylcypromine—MAOA—brain—Alzheimer's disease	0.000183	0.0162	CbGeAlD
Tranylcypromine—CYP2E1—nervous system—Alzheimer's disease	0.00018	0.0159	CbGeAlD
Tranylcypromine—CYP2E1—central nervous system—Alzheimer's disease	0.000173	0.0153	CbGeAlD
Tranylcypromine—Amphetamine—SLC6A4—Alzheimer's disease	0.000173	0.0763	CrCbGaD
Tranylcypromine—CYP2E1—cerebellum—Alzheimer's disease	0.000169	0.0149	CbGeAlD
Tranylcypromine—Phentermine—CYP2D6—Alzheimer's disease	0.000158	0.0697	CrCbGaD
Tranylcypromine—Benzyl alcohol—CYP2D6—Alzheimer's disease	0.000152	0.0672	CrCbGaD
Tranylcypromine—Dextroamphetamine—CYP2D6—Alzheimer's disease	0.00015	0.0665	CrCbGaD
Tranylcypromine—CYP3A4—nervous system—Alzheimer's disease	0.000145	0.0128	CbGeAlD
Tranylcypromine—CYP2D6—nervous system—Alzheimer's disease	0.000143	0.0126	CbGeAlD
Tranylcypromine—CYP3A4—central nervous system—Alzheimer's disease	0.00014	0.0123	CbGeAlD
Tranylcypromine—CYP2E1—brain—Alzheimer's disease	0.000138	0.0121	CbGeAlD
Tranylcypromine—CYP2D6—central nervous system—Alzheimer's disease	0.000137	0.0121	CbGeAlD
Tranylcypromine—CYP2D6—cerebellum—Alzheimer's disease	0.000134	0.0118	CbGeAlD
Tranylcypromine—Amphetamine—CYP2D6—Alzheimer's disease	0.000121	0.0536	CrCbGaD
Tranylcypromine—CYP2D6—brain—Alzheimer's disease	0.000109	0.00961	CbGeAlD
Tranylcypromine—CYP2A6—Metabolism—MAOB—Alzheimer's disease	1.48e-05	0.000252	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.48e-05	0.000251	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.47e-05	0.00025	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.46e-05	0.000248	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.44e-05	0.000246	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS1—Alzheimer's disease	1.44e-05	0.000246	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ENO1—Alzheimer's disease	1.44e-05	0.000246	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.43e-05	0.000244	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.43e-05	0.000243	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GAPDH—Alzheimer's disease	1.42e-05	0.000242	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP2D6—Alzheimer's disease	1.42e-05	0.000241	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	1.41e-05	0.00024	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.4e-05	0.000238	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.39e-05	0.000237	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—MTHFR—Alzheimer's disease	1.38e-05	0.000235	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.38e-05	0.000235	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—A2M—Alzheimer's disease	1.38e-05	0.000234	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.36e-05	0.000232	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.34e-05	0.000228	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—BCHE—Alzheimer's disease	1.34e-05	0.000228	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	1.34e-05	0.000228	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.33e-05	0.000226	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.31e-05	0.000222	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.3e-05	0.000221	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CALM1—Alzheimer's disease	1.29e-05	0.00022	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—APOE—Alzheimer's disease	1.29e-05	0.000219	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PLD3—Alzheimer's disease	1.28e-05	0.000217	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.28e-05	0.000217	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CAV1—Alzheimer's disease	1.28e-05	0.000217	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PLCB1—Alzheimer's disease	1.27e-05	0.000216	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.26e-05	0.000215	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ABCA1—Alzheimer's disease	1.23e-05	0.000209	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.22e-05	0.000208	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CHAT—Alzheimer's disease	1.22e-05	0.000207	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—TPI1—Alzheimer's disease	1.22e-05	0.000207	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ACHE—Alzheimer's disease	1.2e-05	0.000204	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.2e-05	0.000203	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.19e-05	0.000202	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—INPP5D—Alzheimer's disease	1.18e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.18e-05	0.0002	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MAOB—Alzheimer's disease	1.17e-05	0.000199	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.16e-05	0.000197	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.14e-05	0.000194	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	1.13e-05	0.000191	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.13e-05	0.000191	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ENO1—Alzheimer's disease	1.12e-05	0.000191	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS1—Alzheimer's disease	1.12e-05	0.000191	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PPARG—Alzheimer's disease	1.12e-05	0.000191	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.11e-05	0.000189	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—INS—Alzheimer's disease	1.1e-05	0.000187	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP2D6—Alzheimer's disease	1.1e-05	0.000187	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.09e-05	0.000185	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—A2M—Alzheimer's disease	1.09e-05	0.000185	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PPARGC1A—Alzheimer's disease	1.06e-05	0.00018	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—HMOX1—Alzheimer's disease	1.05e-05	0.000179	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—BCHE—Alzheimer's disease	1.04e-05	0.000177	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.03e-05	0.000176	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.03e-05	0.000175	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.02e-05	0.000174	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.02e-05	0.000173	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	9.85e-06	0.000168	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PLCB1—Alzheimer's disease	9.84e-06	0.000167	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—NOS3—Alzheimer's disease	9.65e-06	0.000164	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—LPL—Alzheimer's disease	9.64e-06	0.000164	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ABCA1—Alzheimer's disease	9.54e-06	0.000162	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ACHE—Alzheimer's disease	9.46e-06	0.000161	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	9.45e-06	0.000161	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CHAT—Alzheimer's disease	9.41e-06	0.00016	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TPI1—Alzheimer's disease	9.41e-06	0.00016	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	9.35e-06	0.000159	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.34e-06	0.000159	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	9.09e-06	0.000155	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MAOB—Alzheimer's disease	9.02e-06	0.000153	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ENO1—Alzheimer's disease	8.86e-06	0.000151	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	8.86e-06	0.000151	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTGS2—Alzheimer's disease	8.82e-06	0.00015	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ND1—Alzheimer's disease	8.78e-06	0.000149	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	8.77e-06	0.000149	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	8.69e-06	0.000148	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	8.68e-06	0.000148	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—MTHFR—Alzheimer's disease	8.68e-06	0.000148	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	8.66e-06	0.000147	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	8.66e-06	0.000147	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.59e-06	0.000146	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TPI1—Alzheimer's disease	8.58e-06	0.000146	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CHAT—Alzheimer's disease	8.58e-06	0.000146	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.51e-06	0.000145	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—A2M—Alzheimer's disease	8.39e-06	0.000143	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	8.3e-06	0.000141	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—BCHE—Alzheimer's disease	8.24e-06	0.00014	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MAOB—Alzheimer's disease	8.23e-06	0.00014	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PPARGC1A—Alzheimer's disease	8.22e-06	0.00014	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—HMOX1—Alzheimer's disease	8.18e-06	0.000139	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CALM1—Alzheimer's disease	8.11e-06	0.000138	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—APOE—Alzheimer's disease	8.08e-06	0.000137	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CAV1—Alzheimer's disease	8e-06	0.000136	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	7.99e-06	0.000136	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	7.98e-06	0.000136	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	7.92e-06	0.000135	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	7.83e-06	0.000133	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	7.77e-06	0.000132	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.76e-06	0.000132	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—A2M—Alzheimer's disease	7.71e-06	0.000131	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—A2M—Alzheimer's disease	7.65e-06	0.00013	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	7.54e-06	0.000128	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—LPL—Alzheimer's disease	7.48e-06	0.000127	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.48e-06	0.000127	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TPI1—Alzheimer's disease	7.33e-06	0.000125	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CHAT—Alzheimer's disease	7.33e-06	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ACHE—Alzheimer's disease	7.3e-06	0.000124	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	7.21e-06	0.000123	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PPARG—Alzheimer's disease	7.04e-06	0.00012	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	7.03e-06	0.00012	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—INS—Alzheimer's disease	6.9e-06	0.000117	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ENO1—Alzheimer's disease	6.84e-06	0.000116	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	6.84e-06	0.000116	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.82e-06	0.000116	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	6.77e-06	0.000115	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	6.74e-06	0.000115	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	6.71e-06	0.000114	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	6.71e-06	0.000114	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.69e-06	0.000114	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	6.65e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	6.63e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.63e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	6.58e-06	0.000112	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—A2M—Alzheimer's disease	6.54e-06	0.000111	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	6.5e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	6.47e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	6.36e-06	0.000108	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CALM1—Alzheimer's disease	6.29e-06	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	6.29e-06	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	6.29e-06	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—APOE—Alzheimer's disease	6.27e-06	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	6.23e-06	0.000106	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	6.23e-06	0.000106	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CAV1—Alzheimer's disease	6.21e-06	0.000106	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	6.11e-06	0.000104	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NOS3—Alzheimer's disease	6.05e-06	0.000103	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	6e-06	0.000102	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—LPL—Alzheimer's disease	5.91e-06	0.000101	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.88e-06	0.0001	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	5.85e-06	9.94e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.83e-06	9.91e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	5.81e-06	9.89e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	5.8e-06	9.86e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	5.69e-06	9.67e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.66e-06	9.63e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.66e-06	9.63e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	5.62e-06	9.56e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS2—Alzheimer's disease	5.54e-06	9.42e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	5.52e-06	9.38e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	5.47e-06	9.3e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PPARG—Alzheimer's disease	5.46e-06	9.29e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.43e-06	9.23e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.36e-06	9.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—INS—Alzheimer's disease	5.36e-06	9.11e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	5.35e-06	9.1e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	5.33e-06	9.06e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	5.33e-06	9.06e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	5.32e-06	9.06e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	5.3e-06	9.02e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	5.22e-06	8.89e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.22e-06	8.88e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.04e-06	8.58e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	5.01e-06	8.52e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	4.99e-06	8.48e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CALM1—Alzheimer's disease	4.97e-06	8.46e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—APOE—Alzheimer's disease	4.96e-06	8.43e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	4.95e-06	8.42e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CAV1—Alzheimer's disease	4.91e-06	8.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NOS3—Alzheimer's disease	4.7e-06	7.99e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	4.67e-06	7.95e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.61e-06	7.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.59e-06	7.8e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.58e-06	7.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	4.57e-06	7.77e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—LPL—Alzheimer's disease	4.56e-06	7.76e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	4.55e-06	7.74e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	4.53e-06	7.71e-05	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKT1—Alzheimer's disease	4.43e-06	7.54e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.39e-06	7.46e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.34e-06	7.38e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	4.32e-06	7.34e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	4.3e-06	7.31e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—INS—Alzheimer's disease	4.23e-06	7.2e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.2e-06	7.14e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—LPL—Alzheimer's disease	4.16e-06	7.08e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.11e-06	6.99e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.11e-06	6.99e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	4.11e-06	6.99e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.03e-06	6.86e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	3.9e-06	6.64e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	3.89e-06	6.61e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	3.84e-06	6.53e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APOE—Alzheimer's disease	3.82e-06	6.5e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.82e-06	6.5e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	3.79e-06	6.44e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.78e-06	6.43e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	3.75e-06	6.37e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	3.71e-06	6.32e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.61e-06	6.14e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—LPL—Alzheimer's disease	3.55e-06	6.05e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.53e-06	6e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.52e-06	5.98e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	3.5e-06	5.95e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.5e-06	5.95e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOE—Alzheimer's disease	3.49e-06	5.93e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.48e-06	5.93e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	3.45e-06	5.88e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	3.4e-06	5.78e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	3.33e-06	5.67e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—INS—Alzheimer's disease	3.27e-06	5.56e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	3.2e-06	5.44e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.06e-06	5.21e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.04e-06	5.17e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.01e-06	5.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—INS—Alzheimer's disease	3e-06	5.11e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3e-06	5.1e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.99e-06	5.09e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.98e-06	5.07e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—INS—Alzheimer's disease	2.98e-06	5.07e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.95e-06	5.02e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.86e-06	4.87e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKT1—Alzheimer's disease	2.78e-06	4.73e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.74e-06	4.67e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.64e-06	4.48e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.62e-06	4.46e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.61e-06	4.44e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.6e-06	4.41e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—INS—Alzheimer's disease	2.55e-06	4.33e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.47e-06	4.2e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.41e-06	4.1e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.39e-06	4.06e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.31e-06	3.93e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.3e-06	3.91e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.28e-06	3.88e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.23e-06	3.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKT1—Alzheimer's disease	2.16e-06	3.67e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.04e-06	3.47e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2e-06	3.41e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.96e-06	3.34e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.72e-06	2.93e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.71e-06	2.9e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.58e-06	2.68e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.32e-06	2.24e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.21e-06	2.06e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.2e-06	2.04e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.03e-06	1.75e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	7.92e-07	1.35e-05	CbGpPWpGaD
